Font Size:
a
A
A
Keyword [anti-PD-L1]
Result: 1 - 19 | Page: 1 of 1
1.
Exploration Of The Role Of PD-1/PD-L1 Pathway In HBV Infection
2.
The Therapeutic Effect Of Anti-PD-L1 Monoclonal Antibody And CTL On BALB/c Nude Mice Bearing Lung Cancer
3.
Th Subsets Expression Changed With Antiphospholipid Antibodies
4.
Effect Of Anti-PD-L1 Monoclonal Antibody And EGFR-TKI On PD-L1 Expressed By EGFR Mutated Lung Cancer Cells And Function Of T Lymphocytes
5.
Construction Of CD20 And PD-L1 Dual Targeting Nano-Immune-System And Mechanism Of Synergistic Effect Of Anti-Lymphoma
6.
Study On The Treatment Of Anti-colon Cancer Mediated By The Combination Of DC Vaccine Loaded With Cancer Stem Cells-derived Antigens And Anti-PD-L1 Antibody
7.
Regulating The Tumor Microenvironment Of Pancreatic Cancer By Nanoimmunosystem And Its Synergistically Mechanism In Promoted Chemoradiotherapy
8.
Study On The Construction Of Dual Targeted Nano-immune Cluster Against CD47 And PD-L1 And Its Effect In The Treatment Of Bladder Cancer
9.
Non-invasive Evaluation Of PD-L1 By NIRFI And Therapeutic Effects Of PD-L1 MAb In Type 2 Diabetic Stroke Mice
10.
CuS Nanoparticles-mediated Tumor Hyperthermia Combines Immunotherapy
11.
Effect Of Radiotherapy Combined With Anti-PD-L1 On The Expression Of IL-22 In Mouse Colon Tumor Microenvironment
12.
The Predictive Value And Underlying Mechanisms Of M1 Macrophage For Anti-PD-L1 Therapy Efficacy In Urothelial Cancer
13.
Inhibiting The Immunosuppressive Function Of Myeloid-derived Suppressor Cells Enhanced PD-L1 Blockade-mediated Tumor Immunotherapy
14.
An Experimental Study On Treatment Of Liver Cancer By Sorafenib Loaded Prussian Blue Nanoparticles Combined With Anti-PD-L1 Monoclonal Antibody
15.
SHR-1316,an Anti-PD-L1 Antibody,plus Chemotherapy As The First-line Treatment For Advanced Esophageal Squamous Cell Carcinoma:a Multi-centre,phase 2 Study
16.
Construction Of PD-L1 Blocking Peptide-based Tumor Microenvironment Responsive Nanoplatform And Its Antitumor Research
17.
Tumor Acidity-responsive Nanocarriers For Enhancing The Anti-tumor Efficacy Of Anti-PD-L1 Antibody And Doxorubicin
18.
Comparison Of Receptor Occupancy Methods Of Anti-PD-L1 Monoclonal Antibody In Whole Blood And Pbmc Of Cynomolgus Monkey
19.
Transcriptome Analysis Of Lung Adenocarcinoma And In Vivo Toxicity And Immune Regulation Of Anti-PD-L1 Antibodies
<<First
<Prev Next>
Last>>
Jump to